With the launch of Bio V2 Launchpad, Bio Protocol is building an AI-driven biotech platform that enables researchers and patients worldwide to create and leverage decentralized AI agents (BioAgents) to automate scientific knowledge work and accelerate the commercialization of biotech discoveries.
The $BIO token powers the BioAgent ecosystem and incentivizes contributions. Users can stake $BIO to run BioAgents locally or in the cloud and earn yield.
To date, Bio Protocol has launched three BioAgents in the areas of longevity, menβs health, and microbiome health, with additional BioAgents currently being deployed by BioDAOs across the ecosystem and in partnership with leading researchers.